Your own tumor cells could fight your cancer: new trial tests personalized T-Cell therapy

This phase 2 trial tests a personalized cell therapy called LN-145 for people with certain advanced cancers (like ovarian, breast, thyroid, or bone cancers) that have not responded to treatment or have returned. The therapy uses a patient's own immune cells, taken from their tumor, grown in large numbers, and given back to attack the cancer. The study aims to see if this approach can shrink tumors and control the disease, though it is not expected to be a permanent cure.